| 注册
首页|期刊导航|中国中西医结合杂志|肺泰胶囊联合抗结核治疗方案治疗复治肺结核的临床观察

肺泰胶囊联合抗结核治疗方案治疗复治肺结核的临床观察

王姬 郑雁 冯马龙

中国中西医结合杂志2017,Vol.37Issue(10):1196-1200,5.
中国中西医结合杂志2017,Vol.37Issue(10):1196-1200,5.DOI:10.7661/j.cjim.20170824.203

肺泰胶囊联合抗结核治疗方案治疗复治肺结核的临床观察

Clinical Observation of Anti-tuberculosis Therapeutic Regimen Combined with Feitai Capsule on the Treatment of Retreated Pulmonary Tuberculosis

王姬 1郑雁 2冯马龙1

作者信息

  • 1. 浙江省宁波市奉化区人民医院感染科 浙江315500
  • 2. 浙江省宁波市奉化区疾病预防控制中心 浙江315500
  • 折叠

摘要

Abstract

Objective To observe the clinical efficacy of anti-tuberculosis therapeutic regimen with Feitai Capsule (FC) in the treatment of retreated pulmonary tuberculosis (TB).Methods Totally 113 retreated TB patients were assigned to the treatment group (58 cases) and the control group (55 cases) by random digit table.All patients received routine anti-tuberculosis chemotherapy (3H-R-Z-E/6H-R-E).Those in the treatment group took FC 2.5 g each time,3 times per day.The therapeutic course for all was 9 months.Sputum negative conversation rates after 2,5,8 months,foci absorption and void closure rates after 3,6,9 months,clinical symptoms remission rates after 1 month,and incidence of adverse reactions after 9 months were detected.Results After 2,5,8 months of treatment,the sputum negative conversion rates were 75.00% (21/28),92.86% (26/28),96.43% (27/28) in the treatment group,obviously higher than those of the control group [41.67% (10/24),70.83% (17/24),75.00% (18/24),x2 =5.96,4.92,5.09,P <0.05].After 3,6,9 months of treatment,the total foci absorption rates were 81.03% (47/58),94.83% (55/58),98.28% (57/58) in the treatment group,significantly higher than those of the control group [43.64% (24/55),61.82% (34/55),70.91% (39/55)],x2 =16.91,18.39,16.54,all P <0.01].And the total void closure rates were [70.00% (28/40),87.50% (35/40),95.0%(38/40)] in the treatment group,significantly higher than those of the control group [27.03% (10/37),48.65% (18/37),70.27% (26/37),x2 =14.20,13.52,8.38,P <0.01].The remission rates of cough,expectoration,hemoptysis,fever,fatigue,night sweat and anorexia in the treatment group were all higher than those of the control group (x2 =4.78,5.59,5.40,4.65,4.25,4.79,4.50,P <0.05) after 1 month of treatment.The incidence of adverse reactions in the treatment group was 24.13 % (14/58),and 29.09% (16/55) in the control group,with no statistical difference between the two groups(x2 =0.36,P >0.05).Conclusions Using FC with anti-TB chemotherapeutic drugs to treat retreated TB could effectively improve foci absorption,cavities closure and sputum conversation.

关键词

肺泰胶囊/抗结核治疗/复治肺结核/临床疗效

Key words

Feitai Capsule/anti-tuberculosis therapy/retreated pulmonary tuberculosis/clinical effects

引用本文复制引用

王姬,郑雁,冯马龙..肺泰胶囊联合抗结核治疗方案治疗复治肺结核的临床观察[J].中国中西医结合杂志,2017,37(10):1196-1200,5.

中国中西医结合杂志

OA北大核心CSCDCSTPCDMEDLINE

1003-5370

访问量0
|
下载量0
段落导航相关论文